Medfarma - Company finances
- The company is late in submitting financial data for the previous financial year.
- Latest financial data up to 2024-12-31.
|
EUR
|
2019
From: 2019-04-24
To: 2019-12-31
|
2020
From: 2020-01-01
To: 2020-12-31
|
2021
From: 2021-01-01
To: 2021-12-31
|
2022
From: 2022-01-01
To: 2022-12-31
|
2023
From: 2023-01-01
To: 2023-12-31
|
2024
From: 2024-01-01
To: 2024-12-31
|
|---|---|---|---|---|---|---|
|
Financial data
|
||||||
| Sales revenue | - | - | - | - | 3,591 | 25,284 |
| Profit before tax | -30 | 0 | 0 | 0 | 52 | 1,285 |
| Net profit | -30 | 0 | 0 | 0 | 44 | 1,221 |
| Equity | 0 | 0 | 0 | 0 | 52 | 1,265 |
| Liabilities | - | 0 | 0 | 0 | 0 | 71 |
| Non-current assets | 0 | 0 | 0 | 0 | 0 | 0 |
| Current assets | 0 | 0 | 0 | 0 | 52 | 1,336 |
| Total assets | 0 | 0 | 0 | 0 | 52 | 1,336 |
|
Taxes paid
|
||||||
| STI taxes | - | - | - | - | - | - |
|
Financial indicators
|
||||||
| Revenue change y/y | - | - | - | - | - | +604.1% |
| ROA Return on Assets (ROA). The ratio of net profit to assets. Indicates the company's efficiency. | - | - | - | - | 84.6% | 91.4% |
| ROE Return on equity. The ratio of net profit to equity. Shows the return to shareholders. | - | - | - | - | 84.6% | 96.5% |
| Profit margin Net profit margin. Shows the overall profitability of the company. | - | - | - | - | 1.2% | 4.8% |
| EBT% EBT (Earnings Before Taxes) to revenue ratio. Shows the overall profitability of the company. | - | - | - | - | 1.4% | 5.1% |
| Liabilities/Equity The debt-to-equity ratio shows the company's capital structure. | - | - | - | - | - | 0.1 |
| Revenue per employee Ratio of revenue to the average annual number of employees. Indicates company efficiency. | - | - | - | - | - | - |
Sales revenue
See Scoris data in Google Search
Mark Scoris as a favorite source. One click, no registration.
Medfarma - Social security debts
The amount of overdue SODRA debt for the company Medfarma as of the last working day is: 435 €
| From | To | Debt, € |
|---|---|---|
| 2026-09-05 | 2026-09-15 | 434.70 |
| 2026-08-26 | 2026-09-02 | 434.70 |
| 2026-08-23 | 2026-08-23 | 434.70 |
| 2026-08-19 | 2026-08-19 | 434.70 |
| 2026-08-16 | 2026-08-17 | 434.70 |
| 2026-05-03 | 2026-08-14 | 434.70 |
| 2025-10-01 | 2026-04-30 | 434.70 |
| 2025-09-02 | 2025-09-30 | 362.25 |
| 2025-08-01 | 2025-09-01 | 289.80 |
| 2025-07-01 | 2025-07-31 | 217.35 |
| 2025-06-03 | 2025-06-30 | 144.90 |
| 2025-05-15 | 2025-06-02 | 72.45 |
Medfarma - VMI tax arrears
As of 2026-09-02, the amount of overdue STI tax debt of the company Medfarma is: 92 €
| From | To | Overdue, € |
|---|---|---|
| 2026-09-01 | 2026-09-02 | 91.6 |
| 2026-08-02 | 2026-08-31 | 90.98 |
| 2026-07-09 | 2026-08-01 | 90.06 |
| 2026-03-27 | 2026-07-08 | 13.06 |
| 2026-03-20 | 2026-03-26 | 13.38 |
| 2026-03-11 | 2026-03-19 | 0.32 |
| 2025-08-01 | 2026-03-10 | 13.06 |
| 2025-07-03 | 2025-07-31 | 13.02 |
| 2025-07-01 | 2025-07-02 | 72.28 |
| 2025-06-19 | 2025-06-30 | 72.0 |
| 2025-04-18 | 2025-06-18 | 8.0 |
VMI debt information has been collected since 2024-10-07. Debts for older periods will not be displayed.